Alopecia Induced by Tumor Necrosis Factor-Alpha Antagonists: Description of 52 Cases and Disproportionality Analysis in a Nationwide Pharmacovigilance Database

    March 2014 in “ Rheumatology
    Johana Béné, Guillaume Moulis, Marine Auffret, Guillaume Lefèvre, Pascal Coquerelle, Patrick Coupe, P. Pere, Sophie Gautier
    Image of study
    TLDR Some drugs used to treat inflammation may cause hair loss.
    The study analyzed 282,590 spontaneous adverse drug reaction reports from the French Pharmacovigilance Database, identifying 1068 cases of alopecia, with 52 cases (4.9%) associated with TNF-α antagonist exposure, including drugs like infliximab, adalimumab, etanercept, and certolizumab. A significant association between TNF-α antagonists and alopecia was found, with a pooled reporting odds ratio of 3.0. The study confirmed a strong link between TNF-α antagonist exposure and the occurrence of alopecia, suggesting a class effect, despite TNF-α's known role in inhibiting hair growth and its implication in alopecia areata pathogenesis. The paradox is that while TNF-α antagonists are used to treat inflammatory diseases, they have been reported to induce alopecia, including alopecia areata. The document concludes that there is a confirmed association between TNF-α antagonist exposure and various types of alopecia.
    Discuss this study in the Community →

    Research cited in this study

    5 / 5 results

    Related Community Posts Join

    6 / 1000+ results

    Similar Research

    5 / 1000+ results